ReviewSub-cellular biochemistry2025
Catalytic Droplets: Enzyme Containing Microcompartments.
Review in Sub-cellular biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial microcompartments (BMCs) and biomolecular condensates are two different forms of protein compartmentalization with different aims and functional advantages, representing specific designs of sequestering enzymes or segments of metabolic pathways. BMCs represent special proteinaceous organelles that are entirely composed of protein and are typically characterized by polyhedral shapes. By encapsulating and organizing metabolic enzymes with their substrates and cofactors BMCs act as specialized compartments within bacterial cells that promote and enhance specific biochemical pathways. They also serve important protective functions shielding vulnerable enzymes within a defined microenvironment and sequestering toxic or volatile intermediates. On the other hand, biomolecular condensates (also known as membrane-less organelles, MLOs) are dynamic, cell size-dependent, cytoplasmic and nucleoplasmic entities that typically contain both RNA and protein. They have unique morphologies, specific distribution patterns, are characterized by specific set of resident proteins, but their structural integrity is not supported by encapsulation in the membrane. Instead, their biogenesis is driven by liquid-liquid phase separation, and their structure is entirely controlled and mediated by the protein-protein, protein-RNA, and/or protein-DNA interactions. MLOs represent a different liquid state of cytoplasm or nucleoplasm (or mitochondrial matrix or chloroplastic stroma), whose major biophysical properties are rather similar to those of the rest of the intracellular fluid. Often, MLOs emerge in response to some specific environmental cues, being exploited by cells to respond in real time in a smart stimuli-responsive manner. BMCs are more permanent entities with selective transport through the protein shell. In that way and in many respects, they are closer to intracellular membrane-bounded organelles of eukaryotes than to MLOs. This chapter discusses diverse functions of BMCs and considers the ways by which they contribute to metabolic innovation in bacteria. Some functional roles of MLOs are considered as well.
Indexed as
Identifiers
41004005What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.